Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT01962792
Title Study of the Bruton's Tyrosine Kinase Inhibitor in Combination With Carfilzomib (Kyprolis), in Subjects With Relapsed or Relapsed and Refractory Multiple Myeloma
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Pharmacyclics
Indications
Therapies
Age Groups: adult
Covered Countries USA | CAN

Facility Status City State Zip Country Details
City of Hope Duarte California 91010 United States Details
University of California Los Angeles Los Angeles California 90095 United States Details
Colorado Blood Cancer Institute Denver Colorado 80218 United States Details
University of Nebraska Medical Center Omaha Nebraska 68198 United States Details
New York Presbyterian Hospital - Weill-Cornell New York New York 10021 United States Details
Mount Sinai Hospital New York New York 10029 United States Details
Carolinas Healthcare System Charlotte North Carolina 28204 United States Details
Duke University Medical Center Durham North Carolina 27705 United States Details
University of Cincinnati Cincinnati Ohio 45267 United States Details
Cleveland Clinic Cleveland Ohio 44195 United States Details
Thomas Jefferson University Philadelphia Pennsylvania 19107 United States Details
MUSC Hollings Cancer Center Charleston South Carolina 29425 United States Details
Vanderbilt Ingram Cancer Center Nashville Tennessee 37232 United States Details
University of Texas Southwestern Medical Center Dallas Texas 75390 United States Details
Methodist Healthcare System San Antonio Texas 78229 United States Details
Virginia Commonwealth University Richmond Virginia 23298 United States Details
McGill University Montreal Quebec QC H4A 3J1 Canada Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field